The yoga tycoon’s endorsement of Patanjali products as cures for chronic conditions raises ethical and legal questions.
We rarely make our stories free to read. This one is, so make the most of it.
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
No payment details required
Limited time offer $125 $99 for 1 year
Specialty drugs are fast becoming a lucrative market globally. And India’s largest drugmaker has done well to make the most of this opportunity so far. But it’s too soon to rest easy.
The Supreme Court has mandated all advertisers to submit self-declarations certifying that their ads had no bogus claims. Easier said than implemented.
The moment my account was withheld, my world of learning came crashing down, but then came a sudden realization.